Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Bruxelles  >  Sequana Medical    SEQUA   BE0974340722

SEQUANA MEDICAL

(SEQUA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Bruxelles
11/24/2020 11/25/2020 11/26/2020 11/27/2020 11/30/2020 Date
7.1(c) 7.02(c) 7.12(c) 7.1(c) 7.12 Last
11 440 5 054 4 075 2 695 12 572 Volume
-0.56% -1.13% +1.42% -0.28% +0.28% Change
More quotes
Financials
Sales 2020 1,00 M 1,19 M 1,19 M
Net income 2020 - - -
Net Debt 2020 - - -
P/E ratio 2020 -
Yield 2020 -
Sales 2021 1,00 M 1,19 M 1,19 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 112 M 134 M 134 M
Capi. / Sales 2020 112x
Capi. / Sales 2021 112x
Nbr of Employees 45
Free-Float 87,4%
More Financials
Company
Sequana Medical is a commercial stage company specialized in the development of medical devices for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. In particular, the group offers the alfapump®, a fully implantable, programmable system with CE mark for the management of refractory ascites (chronic accumulation of fluid in the abdomen) due to cirrhosis of the... 
More about the company
All news about SEQUANA MEDICAL
11/19SEQUANA MEDICAL : Announces Positive Interim Data From North American Pivotal al..
AQ
11/19Sequana Medical Announces Positive Interim Data From North American Pivotal a..
GL
11/19SEQUANA MEDICAL : announces positive interim data from North American pivotal al..
PU
11/12SEQUANA MEDICAL : to present at Jefferies 2020 Virtual London Healthcare Confere..
AQ
11/12Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Confer..
GL
11/12SEQUANA MEDICAL : to present at Jefferies 2020 Virtual London Healthcare Confere..
PU
10/22SEQUANA MEDICAL : announces strong interim results from RED DESERT alfapump® DSR..
PU
10/22SEQUANA MEDICAL : Announces Strong Interim Results From RED DESERT alfapump® DSR..
AQ
10/22Sequana Medical Announces Strong Interim Results From RED DESERT alfapump® DS..
GL
10/15SEQUANA MEDICAL : Appoints Two Additional Experts as Heart Failure Scientific Ad..
AQ
10/15Sequana Medical Appoints Two Additional Experts as Heart Failure Scientific A..
GL
09/09SEQUANA MEDICAL : announces September 2020 Investor Conference Schedule
PU
09/09SEQUANA MEDICAL : announces September 2020 Investor Conference Schedule
AQ
09/09Sequana Medical announces September 2020 Investor Conference Schedule
GL
09/03Sequana Medical announces H1 2020 results and provides business update
GL
More news
News in other languages on SEQUANA MEDICAL
2019AVIS D'ANALYSTES DU JOUR : Dassault Aviation, Vinci, Egide, Aryzta, Sabadell, In..
2019Le papetier Sequana, propriétaire d'Arjowiggins, mis en liquidation judiciair..
2019AVIS D'ANALYSTES DU JOUR : Air France, Bouygues, Elior, Korian, Somfy, Ryanair, ..
More news
Chart SEQUANA MEDICAL
Duration : Period :
Sequana Medical Technical Analysis Chart | SEQUA | BE0974340722 | MarketScreener
Technical analysis trends SEQUANA MEDICAL
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 14,00 €
Last Close Price 7,12 €
Spread / Highest target 96,6%
Spread / Average Target 96,6%
Spread / Lowest Target 96,6%
Managers
NameTitle
Ian Crosbie Chief Executive Officer & Executive Director
Pierre Hubert Andre Chauvineau Chairman
Kirsten van Bockstaele Chief Financial Officer
Oliver Gödje Chief Medical Officer
Dirk Fengels Global Vice President-Engineering & Manufacturing
Sector and Competitors
1st jan.Capitalization (M$)
SEQUANA MEDICAL13.42%134
MODERNA, INC.549.44%50 267
LONZA GROUP AG56.23%45 319
CELLTRION, INC.82.04%40 460
IQVIA HOLDINGS INC.9.26%32 365
SEAGEN INC.48.01%30 493